Literature DB >> 2149974

Clinical aspects of Down syndrome from infancy to adulthood.

S M Pueschel1.   

Abstract

In past decades, most individuals with Down syndrome were usually not afforded adequate medical care. Many children with Down syndrome were institutionalized and they were often deprived of all but the most elementary medical services. Fortunately, there have been major improvements in the health care provision during the past 20 years. Professionals who are providing services to persons with Down syndrome need to be aware of those clinical conditions that are more often observed in this population. Certain congenital anomalies (congenital cataracts, anomalies of the gastrointestinal tract, and congenital heart disease) often require immediate attention, as some of them may be life threatening. During the subsequent childhood years a number of clinical conditions and disorders such as infectious diseases, increased nutritional intake, periodontitis, seizure disorders, sleep apnea, visual impairment, audiologic deficits, thyroid dysfunction, and skeletal problems usually occur at a higher prevalence. During adolescence specific aspects of maturation and certain health issues (skin infections, thyroid disorders, increased weight gain, and others) as well as mental health concerns need to be taken into consideration. Similar concerns may also be observed during adulthood which in addition is often marked by accelerated aging and the threat of Alzheimer disease in some persons with Down syndrome. Special attention needs to be paid to these disorders and conditions during the lifetime of a person with Down syndrome. Appropriate medical care should be provided to and no form of treatment should be withheld from a person with Down syndrome that would be given unhesitatingly to an individual without this chromosome disorder.

Entities:  

Mesh:

Year:  1990        PMID: 2149974     DOI: 10.1002/ajmg.1320370708

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  14 in total

1.  Cortical and trabecular bone at the radius and tibia in male and female adolescents with Down syndrome: a peripheral quantitative computed tomography (pQCT) study.

Authors:  A González-Agüero; G Vicente-Rodríguez; A Gómez-Cabello; J A Casajús
Journal:  Osteoporos Int       Date:  2012-06-09       Impact factor: 4.507

2.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

3.  Recurrent cerebral embolism in a young adult with Down's syndrome. A case report.

Authors:  Shimon Ishida; Masamichi Date; Yoshimitsu Doi; Toshihiko Sato; Masakazu Sugino; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

4.  New and old directions.

Authors:  Frank Buckley
Journal:  Downs Syndr Res Pract       Date:  2007-07

5.  Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

Authors:  J London; F K Ndiaye; L C Bui; B Souchet; F Daubigney; C Magnan; S Luquet; J Dairou; N Janel; C Rouch
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

6.  Adults with Down's syndrome: the prevalence of complications and health care in the community.

Authors:  Alex Henderson; Sally A Lynch; Steve Wilkinson; Morag Hunter
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

7.  Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.

Authors:  Jacqueline London; Claude Rouch; Linh Chi Bui; Elodie Assayag; Benoit Souchet; Fabrice Daubigney; Hind Medjaoui; Serge Luquet; Christophe Magnan; Jean Maurice Delabar; Julien Dairou; Nathalie Janel
Journal:  Mol Neurobiol       Date:  2017-05-25       Impact factor: 5.590

8.  Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Authors:  Juliet A Moncaster; Roberto Pineda; Robert D Moir; Suqian Lu; Mark A Burton; Joy G Ghosh; Maria Ericsson; Stephanie J Soscia; Anca Mocofanescu; Rebecca D Folkerth; Richard M Robb; Jer R Kuszak; John I Clark; Rudolph E Tanzi; David G Hunter; Lee E Goldstein
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field.

Authors:  M E Coussons-Read; L S Crnic
Journal:  Behav Genet       Date:  1996-01       Impact factor: 2.805

10.  Cardiac and sympathetic activation are reduced in children with Down syndrome and sleep disordered breathing.

Authors:  Denise M O'Driscoll; Rosemary S C Horne; Margot J Davey; Sarah A Hope; Vicki Anderson; John Trinder; Adrian M Walker; Gillian M Nixon
Journal:  Sleep       Date:  2012-09-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.